APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON MAY 11, 2023ApyxMedical2025-12-12T19:03:58+00:00April 5, 2023|Read More
RENUVION WINS ADDY AWARD FOR #THISISME CAMPAIGNApyxMedical2025-12-12T19:04:30+00:00March 27, 2023|Read More
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2023 FINANCIAL OUTLOOKApyxMedical2025-12-12T19:05:09+00:00March 16, 2023|Read More
APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO COAGULATE AND CONTRACT SOFT TISSUES, INCLUDING SUBCUTANEOUS TISSUE, WHERE NEEDEDApyxMedical2025-12-12T19:05:39+00:00February 27, 2023|Read More
APYX MEDICAL CORPORATION ANNOUNCES NEW FIVE-YEAR CREDIT AGREEMENT WITH MIDCAP FINANCIALApyxMedical2025-12-12T19:06:56+00:00February 21, 2023|Read More
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIAL RESULTS ON MARCH 16, 2023ApyxMedical2025-12-12T19:07:24+00:00February 16, 2023|Read More
RENUVION COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON ‘THE BALANCING ACT’ TALK SHOW ON LIFETIME FEBRUARY 13ApyxMedical2025-12-12T19:07:54+00:00February 9, 2023|Read More
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF THE RENUVION APR HANDPIECE FOR THE COAGULATION OF SUBCUTANEOUS SOFT TISSUES WHERE NEEDED, FOLLOWING LIPOSUCTIONApyxMedical2025-12-12T19:08:24+00:00February 1, 2023|Read More
APYX MEDICAL CORPORATION LAUNCHES NEW ‘APYX ONE CONSOLE’ FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATESApyxMedical2025-12-12T19:10:24+00:00January 25, 2023|Read More
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 REVENUE RESULTSApyxMedical2025-12-12T19:11:04+00:00January 10, 2023|Read More
APYX MEDICAL CORPORATION EMBARKS ON INAUGURAL BRAND CAMPAIGN FOR RENUVIONApyxMedical2025-12-12T19:11:47+00:00January 3, 2023|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER SANDLER 34TH ANNUAL HEALTHCARE CONFERENCEApyxMedical2025-12-12T19:12:19+00:00November 22, 2022|Read More
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND UPDATES FULL YEAR 2022 FINANCIAL OUTLOOKApyxMedical2025-12-12T19:12:51+00:00November 10, 2022|Read More
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS ON NOVEMBER 10, 2022ApyxMedical2025-12-12T19:13:25+00:00September 26, 2022|Read More
‘BOTCHED’ TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION HELIUM PLASMA TECHNOLOGY IN COSMETIC PROCEDURESApyxMedical2025-12-12T19:13:52+00:00September 13, 2022|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE LAKE STREET BEST IDEAS GROWTH CONFERENCEApyxMedical2025-12-12T19:14:14+00:00September 6, 2022|Read More
